Categories: BrainNews

Ibogaine By David Dardashti: Government Urged to Increase Funding for Quantum Electrodynamics Research

Exploring the Relationship Between Glial Cells and Electromagnetic Waves

David Dardashti and Quantum Electrodynamic

Ibogaine By David Dardashti supports quantum electrodynamics

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) — Ibogaine By David Dardashti today announced that they are advocating to the government to increase funding allocated for research into the relationship between glial cells and electromagnetic waves.

Catalyzing Glial Cells

Ibogaine hydrochloride has been used to catalyze the production of glial cells in response to electromagnetic waves within the brain. “Maxwell’s unified field theory suggests that electric current and light particles have the potential to create a high level of interconnectivity, which can be used to measure photon emission. By studying electroencephalogram readings during ibogaine treatment, we can predict electromagnetic waves that may enhance utilization the photoelectric effect process. This could be used to maximize solar power efficiency and create economic and environmental benefits.” Ibogaine By David Dardashti plans to share this proposition with a major U.S. legal organization and is expecting a positive response. “We feel strongly that this research has the potential to open massive doors for a more sustainable future. It will be one of our great pursuits to make this vision a reality and to create a safe, healthy, and prosperous society,” said Dr. Dardashti.

Ibogaine hydrochloride has the potential to be used to measure photon emission in response to electromagnetic waves, offering new economic and environmental benefits and providing a more sustainable future.

Ibogaine By David Dardashti encourages the U.S. government to increase funding for research initiatives that explore the relationship between glial cells and electromagnetic waves.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e13e14b0-f2f2-4b61-8094-dd33564c00e9

CONTACT: Gavriel Dardashti
+17869301880
gavriel@ibogaineclinic.com

Staff

Recent Posts

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

13 hours ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

13 hours ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

13 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

13 hours ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

13 hours ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…

13 hours ago